Aseman (Tara) TehraniMultispecific antibodies in oncologyIntro to Multispecific antibodies2d ago2d ago
Aseman (Tara) TehraniTri-Specific Nano-Antibodies in Cancer ImmunotherapyOvercoming Tumor Immune Evasion with Tri-Specific Nano-AntibodiesJul 29Jul 29
Aseman (Tara) TehraniTevimbra (Tislelizumab): A Breakthrough in immune checkpoint therapyImmune checkpoint therapy (ICT) is a form of cancer therapy that targets co-inhibitory or stimulatory molecules, enabling T cells to…Jun 27Jun 27
Aseman (Tara) TehranisiRNA Delivery via PLANAs: Revolutionizing Cancer Gene SilencingWhat is siRNA?Jun 19Jun 19
Aseman (Tara) TehraniDecoding DNA ReplicationIn this article, we’ll explore the molecular principles behind one of the key processes central to genetics: DNA Replication. Let’s dive…Jun 16Jun 16